Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitoxantrone: potential for use in intensive therapy.

C F LeMaistre1, R Herzig

  • 1University of Texas, M.D. Anderson Cancer Center, Department of Hematology, Houston, TX 77030.

Seminars in Oncology
|February 1, 1990
PubMed
Summary

Mitoxantrone, a synthetic anthraquinone, shows promise for intensive cancer therapy due to its dose-response effect and manageable toxicity. Clinical data support its substantial dose escalation for enhanced treatment efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and outcomes of routine endovascular thrombectomy in large artery occlusion recorded in the SITS Register: An observational study.

Journal of internal medicine·2021
Same author

Safety and efficacy of mechanical thrombectomy with stent-retrievers in anticoagulated patients with anterior circulation stroke.

Clinical radiology·2018
Same author

Correction to: Multidisciplinary approach in the treatment of spinal dural arteriovenous fistula-results of endovascular and surgical treatment.

Acta neurochirurgica·2018
Same author

Multidisciplinary approach in the treatment of spinal dural arteriovenous fistula-results of endovascular and surgical treatment.

Acta neurochirurgica·2018
Same author

Transcranial Sonography of the Insula: Digitized Image Analysis of Fusion Images with Magnetic Resonance.

Ultraschall in der Medizin (Stuttgart, Germany : 1980)·2016
Same author

Inoculation methods using Rhodococcus erythropolis strain P30 affects bacterial assisted phytoextraction capacity of Nicotiana tabacum.

International journal of phytoremediation·2015

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Mitoxantrone is a synthetic anthraquinone used in cancer therapy.
  • Standard doses exhibit primarily myelosuppressive toxicity with minimal extramedullary effects.

Purpose of the Study:

  • To review data supporting mitoxantrone's use in intensive therapy regimens.
  • To examine clinical evidence for substantial dose escalation of mitoxantrone.

Main Methods:

  • Literature review of preclinical and clinical data.
  • Analysis of toxicity profiles at various doses.
  • Evaluation of dose-response relationships in vitro.

Main Results:

  • Mitoxantrone demonstrates a dose-response effect in vitro.
  • Clinical data suggest significant dose escalation is feasible.

Related Experiment Videos

  • Toxicity remains primarily myelosuppressive even at higher doses.

    • Conclusions:

    • Mitoxantrone is a viable candidate for intensive chemotherapy regimens.
    • Dose escalation of mitoxantrone may enhance therapeutic outcomes.
    • Its favorable toxicity profile supports further investigation in escalated dosing.